Skip to main content

9 3 5215 Pill: yellow, capsule/oblong, 13mm

The pill with imprint 9 3 5215 (Yellow, Capsule/Oblong, 13mm) has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 25 mg / 15 mg and is used for High Blood Pressure. It belongs to the drug class ACE inhibitors with thiazides and is not a controlled substance.

Images for 9 3 5215

Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Front
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215 Back
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215
Hydrochlorothiazide and moexipril hydrochloride 25 mg / 15 mg 9 3 5215

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
9 3 5215
Strength
25 mg / 15 mg
Color
Yellow
Size
13.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
lactose monohydrate, magnesium stearate, povidone k30, sodium bicarbonate, polyethylene glycol 3350, magnesium silicate, titanium dioxide, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-5215 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0578 (Discontinued) AvKare, Inc.
54868-3443 (Discontinued) Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.